Sci. STKE, 7 November 2000
Immunology Granzyme B Receptor
One key component of the mechanism by which cytotoxic T lymphocytes (CTLs) attack virus-infected or tumor cells is release of cytolytic molecules like the protease granzyme B (grB). Motyka et al. report the discovery that grB uptake is mediated by a receptor--the cation-independent mannose 6-phosphate receptor (CI-MPR), also known as the insulin-like growth factor II receptor. Mouse fibroblast L cells lacking CI-MPR were resistant to apoptosis caused by grB. In a transplant rejection model in mice, donor cells that expressed CI-MPR were rejected, whereas cells lacking the receptor remained and expanded. The CI-MPR provides a potential target for therapeutic modulation of CTL-induced killing.
Motyka, B., Korbutt, G., Pinkoski, M.J., Heibein, J.A., Caputo, A., Hobman, M., Garry, M., Shostak, I., Sawchuk, T., Holmes, C.F.B., Gauldie, J., and Bleackley, R.C. (2000) Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103:491-500. [Online Journal]
Citation: Granzyme B Receptor. Sci. STKE 2000, tw8 (2000).
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882